Home / Treatment & Care Decisions
Monitoring Treatment Response
Monitoring brings together symptoms, everyday function, clinical findings and tests to assess treatment benefits and harms over time.
#A review should return to the purpose of treatment
NICE's medicines-adherence guidance recommends explaining treatment aims and asking what the person hopes treatment will achieve. It also recommends reviewing the prescribing decision and the person's concerns at agreed intervals. Its structured-medication-review standard describes reaching agreement about treatment while reducing medicine-related problems.
For medicines, a useful review connects the original aim with the person's experience so far. These sources concern medicines; they do not establish a monitoring protocol for every treatment. Mynd cannot decide whether a treatment is working for an individual.
Evidence: NICE: medicines adherence / NICE: structured medication review
#Benefit, unwanted effects and practical use belong in the same discussion
NICE's structured-review account includes the person's views, past adverse reactions, risk factors and any monitoring needed. Its adherence guidance explains that people may assess medicines using their own symptoms or concerns, and that clinicians need to understand how medicines are actually being used. A review therefore needs more context than a simple satisfied-or-unsatisfied answer.
Describe changes, concerns and actual medicine use to the prescriber or pharmacist. Ask what outcomes or checks matter for this treatment. This page provides no test thresholds, review intervals or permission to change doses based on symptoms or measurements.
Evidence: NICE: structured medication review / NICE: medicines adherence
#Agree what happens after the review
NICE recommends reviewing medicines according to the person's choice and need. Where difficulties with adherence are found, it calls for identifying causes, agreeing action and including a follow-up review date. It also stresses communication between the professionals involved in prescribing, dispensing and reviewing medicines.
Clarify who will review the plan, when, and how concerns should be raised before that appointment. A planned review is not a reason to postpone seeking care for a new problem. The care team must give product- and condition-specific instructions; this page offers no emergency assessment or safety-clearance decision.
Evidence: NICE: medicines adherence
Source note
The sections above were checked against the linked sources. No clinical review has been performed. This is general research education, not a clinical guideline.